CHS 828
Alternative Names: GMX 1778Latest Information Update: 19 Jun 2024
Price :
$50 *
At a glance
- Originator LEO Pharma
- Class Antineoplastics; Guanidines; Pyridines; Small molecules
- Mechanism of Action Nicotinamide phosphoribosyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 05 Apr 2024 Pharmacodynamics data from a preclinical study in Cancer presented at the 115th Annual Meeting of the American Association for Cancer Research (AACR-2024)
- 13 May 2003 Discontinued - Phase-II for Cancer in Europe (PO)
- 17 Apr 2003 A preclinical study has been added to the Cancer pharmacodynamics section